Addenda: Aug. 9, 10 & Sept. 1, 2000
Addenda: Aug. 9, 10 & Sept. 1, 2000
The following two questions were submitted to the CBBS e-network for discussion based on the following clinical case. A physician ordered washed cells for what he called a "micro-premie" (presumably a very low birth weight premature infant). The ordering physician was worried over the potassium levels in a unit of any age, even a fresher unit.
Question #1. What are your opinions regarding the ordering of washed red cells for premature and low birth weight neonates to avoid the risk of transfusing excess potassium?
Question #2. What do you or your hospitals consider "fresh" for neonatal transfusions?
Before distributing these question to the network, I previewed these questions with two experts in neonatal transfusion practice. Here is what these experts had to say:
The first expert said that there have been several papers published that support the conclusions of an article published in the Am J Clin Pathol 1997 Apr;107(4 Suppl 1):S57-63, entitled 'Practical issues in neonatal transfusion practice.' In that article, the author stated that small premature infants frequently require transfusions of blood components, particularly red blood cells (RBCs), during the first weeks of life. Although great efforts have been made during the past few years to optimize the transfusion of blood components to these tiny patients, several questions have not been definitively answered. Accordingly, transfusion practices vary among neonatologists. The purpose of this article was to assess the available data critically. The findings indicated that stored RBCs can be transfused safely into premature infants to diminish donor exposures. It was also found that leukocyte-reduced blood components can be used to prevent the transmission of cytomegalovirus; thus, cellular components do not need to be obtained exclusively from donors negative for antibodies to cytomegalovirus. However, gamma-irradiation of cellular blood components cannot be justified for all neonatal transfusions. Obviously, as new information is reported, these findings may require revision. According to this expert, in the USUAL small volume setting, transfused K+ is not a problem. Finally, this expert says that his institution does not have a definition for 'fresh RBCs' -- however, the maximum storage age for a blood product MUST be defined differently for different clinical circumstances.
The second expert said that if you calculate the amount of free potassium infused with each aliquot of RBC, you will find that the amount of free potassium in an aliquot of older, irradiated RBC is about a "maintenance" potassium dose. It is nowhere near the size of a therapeutic potassium bolus. Therefore, potassium is not a concern with aliquot transfusions. Potassium can become a concern in massive transfusion, however, if the amount of free potassium infused is significant. Even in massive transfusion, however, potassium-depleted red blood cells will re-absorb the potassium after transfusion, and potassium will also be absorbed by the cells of the transfusion recipient. The patients most at risk of hyperkalemia during massive transfusion appear to be those whose cells are unable to absorb the potassium bolus, i.e., those with underlying acidemia and hyperkalemia. This expert was not familiar with any literature that compares premies to larger children as to their ability to absorb potassium. The expert also commented that at her institution they recommend less than one-week old blood for exchanges. Her institution used to recommend blood less than two weeks old, if possible, for neonatal surgeries, but they do not do this any more because it was impossible to enforce. In meetings with pediatric anesthesiologists, they were only concerned about two patient populations - the pediatric liver and the kidney transplant patients. For these patients, the pediatric anesthesiologists have requested non-irradiated blood, as they feel that the potassium load can be clinically problematic in these patients. In the liver patients, apparently, the ischemic liver cells can release free potassium when the liver is manipulated, and the anesthesiologists want to minimize the additional potassium load in transfused blood. The liver transplant surgeon agrees that hyperkalemia is a problem during liver transplantation but disagrees that the transfusion plays a clinically significant role in this problem. The kidney transplant patients may start out hyperkalemic if they haven't been dialyzed recently, and therefore have less ability to absorb the free potassium in transfused blood. Washing is usually not a realistic option for surgery patients because we cannot predict how many units the patients will need, and if they suddenly start bleeding during surgery there is not enough time to wash units.
ADDENDA Sept. 1, 2000, submitted by a fourth network member:
Submit comments to the e-Network Forum at enetworkforum@cbbsweb.org
Ira A. Shulman, MD
CBBS e-Network Forum Senior Editor & Moderator
W. Tait Stevens, MD
CBBS e-Network Forum Editor & Moderator
Elizabeth M. St. Lezin, MD
CBBS e-Network Forum Associate Editor & Moderator